GlassScriptPhysician profile
Gene Zitser
NPI 1710924964
$21,743.25
in general payments reported to CMS, 2019-2025
63 companies · $2,445 in 2025
The $2,445 reported for 2025 was more than what 76% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,215 · 2020: $3,600 · 2021: $3,568 · 2022: $3,150 · 2023: $3,200 · 2024: $2,566 · 2025: $2,445.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,834 · Education: $376.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,834.28 |
| Education | $376.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $2,705.99 | 2019-2025 | Austedo Xr, Austedo Xr, Austedo |
| Abbvie INC. | $2,487.80 | 2019-2025 | Qulipta, Botox, Ubrelvy |
| Ucb, INC. | $1,727.41 | 2019-2025 | Briviact, Nayzilam |
| Allergan, INC. | $1,526.86 | 2019-2022 | |
| Neurocrine Biosciences, INC. | $1,467.53 | 2019-2025 | Ingrezza, Ongentys |
| Neurelis, INC. | $1,123.51 | 2020-2025 | Valtoco |
| Genzyme Corporation | $760.94 | 2019-2022 | |
| Biogen, INC. | $722.84 | 2019-2023 | Vumerity, Tysabri |
| Supernus Pharmaceuticals, INC. | $709.60 | 2019-2023 | Qelbree |
| Pfizer INC. | $707.61 | 2019-2025 | |
| Sk Life Science, INC. | $690.76 | 2020-2025 | Xcopri |
| Eisai INC. | $604.27 | 2019-2025 | |
| Harmony Biosciences LLC | $470.64 | 2020-2025 | |
| Scilex Pharmaceuticals INC. | $448.95 | 2019-2024 | Ztlido |
| Adamas Pharmaceuticals, INC. | $401.55 | 2019-2021 |
Show all 63 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gene Zitser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.